Want to join the conversation?
$MNK's 2Q16 net sales rose 2.1% versus 2Q15, mainly driven by growth in Specialty Brands due to inclusion of Inomax and Therakos net sales. Specialty Generics net sales fell 27.1% due to dip in net sales of some products. Nuclear Imaging net sales fell 6.7% due to lower net sales of generators and an unfavorable exchange rate impact.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?